TABLE 4.
Multiple regression analysis of the combined influence of clinical characteristics and treatment of type variables on VAS in patients with KOA.
| Variables | B | SE | β | t | P |
|---|---|---|---|---|---|
| Constant | 4.18 | 1.08 | - | 3.87 | <0.001 |
| Type of treatment* | −0.90 | 0.19 | −0.45 | −4.96 | <0.001 |
| Sex* | −0.22 | 0.26 | -0.09 | -0.83 | 0.413 |
| Age | 0.02 | 0.01 | 0.23 | 2.18 | 0.034 |
| BMI | 0.01 | 0.03 | 0.05 | 0.45 | 0.654 |
| K-L Grade* | 0.68 | 0.15 | 0.48 | 4.64 | <0.001 |
Model summary: r = 0.575; p < 0.001. Coefficient B indicates the number of units that the dependent variable increases by for each increase in the unit of the independent variable. SE, is the standard error. The coefficient β is the standardized coefficient B. VAS, visual analogue scale; KOA, knee osteoarthritis; BMI, body mass index; K-L; Kellgren-Lawrence; *The hyaluronic acid group, the male, and Kellgren-Lawrence grade I served as the control group, respectively. Boldface indicates the significant differences in p value.
The bold values indicate a significant difference in the dependent variable caused by the change in the independent variable.